The Drug Price Restriction lets multinational companies walk away on investments in the Korean market
Although multinational companies are actively investing on the Asian market, it is known that they have avoided the Korean market.
The reason was indicated to the excessive drug price reduction policy.
According to the Korean Research-based Pharma Industry Association’s (KRPIA) report titled th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
